Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study

被引：0
|
作者：
Massimiliano Ruscica
Chiara Macchi
Angelica Giuliani
Alessandra Stefania Rizzuto
Deborah Ramini
Matilde Sbriscia
Stefano Carugo
Anna Rita Bonfigli
Alberto Corsini
Fabiola Olivieri
Jacopo Sabbatinelli
机构：
[1] Università degli Studi di Milano,Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”
[2] Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico,Department of Cardio
[3] Università Politecnica Delle Marche,Thoracic
[4] Università degli Studi di Milano,Vascular Diseases
[5] IRCCS INRCA,Department of Clinical and Molecular Sciences
[6] IRCCS INRCA,Department of Clinical Sciences and Community Health
[7] Azienda Ospedaliero Universitaria Delle Marche,Clinic of Laboratory and Precision Medicine
来源：
Cardiovascular Diabetology | / 22卷
关键词：
Proprotein Convertase Subtilisin/kexin type 9; Type 2 diabetes mellitus; Cardiovascular risk; Major adverse cardiovascular events; All-cause mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study
    Ruscica, Massimiliano
    Macchi, Chiara
    Giuliani, Angelica
    Rizzuto, Alessandra Stefania
    Ramini, Deborah
    Sbriscia, Matilde
    Carugo, Stefano
    Bonfigli, Anna Rita
    Corsini, Alberto
    Olivieri, Fabiola
    Sabbatinelli, Jacopo
    [J]. CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] PLASMA PCSK9 AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES
    El Khoury, Petra
    Roussel, Ronan
    Fumeron, Frederic
    Velho, Gilberto
    Jacob, Marie-Paule
    Steg, Gabriel
    Potier, L.
    Ghaleb, Youmna
    Elbitar, Sandy
    Abifadel, Marianne
    Boileau, Catherine
    Marre, Michel
    Varret, Mathilde
    Hansel, Boris
    [J]. ATHEROSCLEROSIS, 2017, 263 : E81 - E81
  • [3] Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study
    Ruscica, Massimiliano
    Macchi, Chiara
    Gandini, Sara
    Macis, Debora
    Guerrieri-Gonzaga, Aliana
    Aristarco, Valentina
    Serrano, Davide
    Lazzeroni, Matteo
    Rizzuto, Alessandra Stefania
    Gaeta, Aurora
    Corsini, Alberto
    Gulisano, Marcella
    Johansson, Harriet
    Bonanni, Bernardo
    [J]. CANCERS, 2024, 16 (07)
  • [4] Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease - 10-year follow-up of the Hoorn Study
    Becker, A
    Bos, G
    de Vegt, F
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 (15) : 1406 - 1413
  • [5] Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes
    El Khoury, Petra
    Roussel, Ronan
    Fumeron, Frederic
    Abou-Khalil, Yara
    Velho, Gilberto
    Mohammedi, Kamel
    Jacob, Marie-Paule
    Steg, Philippe Gabriel
    Potier, Louis
    Ghaleb, Youmna
    Elbitar, Sandy
    Ragot, Stephanie
    Andreata, Francesco
    Caligiuri, Giusepinna
    Hadjadj, Samy
    Boileau, Catherine
    Marre, Michel
    Abifadel, Marianne
    Varret, Mathilde
    Hansel, Boris
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 943 - 953
  • [6] Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study
    Turgunova, L.
    Baidildina, B.
    Laryushina, Y.
    Koichubekov, B.
    Turmukhambetova, A.
    Akhmaltdinova, L.
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [7] The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study
    Bertolani, Arianna
    Ravasio, Roberto
    Raimondo, Paola
    Jommi, Claudio
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2022, 9 : 73 - 81
  • [8] Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study
    Ranjit Mohan Anjana
    Coimbatore Subramanian Shanthirani
    Ranjit Unnikrishnan
    Poongkunran Mugilan
    Anandakumar Amutha
    Haridas Divya Nair
    Sivasankaran Subhashini
    Ulagamathesan Venkatesan
    Mohammed K. Ali
    Harish Ranjani
    Viswanathan Mohan
    [J]. Acta Diabetologica, 2015, 52 : 601 - 609
  • [9] Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study
    Anjana, Ranjit Mohan
    Shanthirani, Coimbatore Subramanian
    Unnikrishnan, Ranjit
    Mugilan, Poongkunran
    Amutha, Anandakumar
    Nair, Haridas Divya
    Subhashini, Sivasankaran
    Venkatesan, Ulagamathesan
    Ali, Mohammed K.
    Ranjani, Harish
    Mohan, Viswanathan
    [J]. ACTA DIABETOLOGICA, 2015, 52 (03) : 601 - 609
  • [10] Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes - A 7-year follow-up study
    Ko, Seung-Hyun
    Park, Shin-Ae
    Cho, Jae-Hyoung
    Song, Ki-Ho
    Yoon, Kun-Ho
    Cha, Bong-Yun
    Son, Ho-Young
    Yoo, Ki-Dong
    Moon, Keon-Woong
    Park, Yong-Moon
    Ahn, Yu-Bai
    [J]. DIABETES CARE, 2008, 31 (09) : 1832 - 1836
12345